Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


Titian Software launches Mosaic 4.0

Product Image
Product Description

Titian Software has recently launched version 4.0 of its Mosaic Sample Management software. Mosaic is already established as the leading sample management software for small molecule compound libraries, and is used by ten of the top 20 pharma companies. Applications of the new Mosaic 4.0 are extended to the enterprise-wide management of biological samples and reagents in many different types of life science research organisations in industry and academia.

Mosaic 4.0 builds on the proven strengths of earlier versions, including modular scalability, advanced instrument integration, and comprehensive audit trail and genealogy tracking. In response to the specific requirements of biological sample management, Mosaic 4.0 now incorporates enhanced modules for tracking manually-accessed stores and manual operations, such as hand pipetting, for smaller-scale operations. A new built-in Substance Registration System handles the allocation of substance identifiers and the capture of substance metadata, and Mosaic can still seamlessly link to external registration systems if required. For higher-throughput laboratories, Mosaic 4.0 builds on its workflow management capability and wide array of integration modules for automated stores, liquid handlers and other instruments. The new functionality makes version 4.0 well-suited to the management of clinical trial samples and reagents, therapeutic and anti-drug antibodies (ADA), cell lines and biobank samples – in addition to small molecule compounds.

“The next generation Mosaic 4.0 was conceived in response to customer demand”, said Richard Fry, Titian’s Director of Business Development. “The new functionality to handle biological samples has been developed in close partnership with our customers in leading pharma and biotech companies, and I’m particularly pleased that the first installation of Mosaic 4.0 is in a validated environment in clinical trials. Our goal with version 4.0 is to build on our track record in compound management to establish Mosaic as the software of choice for the management of all sample types.”

Product Titian Software launches Mosaic 4.0
Company Titian Software
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified

Titian Software






Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!